Method for specifically detecting asparaginase activity by combining immunomagnetic separation with substrate peptide through LC-MS / MS (Liquid Chromatography-Mass Spectrometry / Mass Spectrometry)
By coupling asparaginase antibodies on magnetic nanoparticles and combining LC-MS/MS technology, the low sensitivity and interference of asparaginase activity detection in biological samples were solved, and high sensitivity asparaginase activity was achieved Monitoring, supporting the adjustment of drug treatment plans and allergic prevention.
Patent Information
- Application Number
- CN202411028344.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-30
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2044-07-30
AI Technical Summary
The existing asparaginase activity detection methods are low in sensitivity, easily disturbed and costly in biological samples, which are difficult to meet the needs of large-scale detection and cannot directly monitor protease activity in the body, resulting in drug treatment plans and allergic prevention guidance. limit.
Immunomagnetic beads were prepared by amide reaction mediating the coupling of asparagine antibody to the surface of magnetic nanoparticles. Combined with LC-MS/MS technology, aspartic acid was generated through immunomagnetic separation and specific shearing of substrate peptides, and established Asparaginase activity-mass spectrometry response signal standard curve realizes high-sensitivity asparaginase activity detection.
It improves the sensitivity and specificity of asparaginase activity detection, avoids interference from biological samples, simplifies the operation process, can effectively monitor asparaginase activity in the body, guides the adjustment of drug treatment plans and prevents allergic reactions.
Smart Images

Figure CN119023960A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of medical detection, in particular to a method for detecting asparaginase activity in a sample by LC-MS / MS based on specific substrate peptides. Background Art
[0002] With the rapid development of biomedicine, protease drugs have been widely developed and applied to the diagnosis and treatment of diseases. L-asparaginase is an asparagine-specific enzyme that specifically catalyzes the hydrolysis of asparagine in the blood to form L-aspartic acid and ammonia, so that tumor cells cannot take up enough L-asparagine, thereby inhibiting cell proliferation and achieving the purpose of anti-tumor. It is an important anti-tumor drug used clinically for acute lymphoblastic leukemia, etc. However, it is easy to cause serious allergic reactions such as allergies and thrombosis. Monitoring its biological activity in the body is an important research content for evaluating drug efficacy and ensuring drug safety. The present invention aims to explore a new high-sensitivity and exclusive analytical method for monitoring the activity of protease drugs in vivo asparaginase.
[0003] Monitoring the activity level of asparaginase in the body has important guiding value for the monitoring and prevention of its allergic reactions and the adjustment of treatment plans. However, to date, domestic and foreign countries have only adjusted the treatment plan through the follow-up treatment of asparaginase allergic reactions, or indirectly evaluated the in vivo efficacy of asparaginase by monitoring the amino acid asparagine in the body. Direct monitoring of its activity level in the body has not yet been popularized.
[0004] Asparaginase has high biological activity, small clinical dosage, and low in vivo concentration level, which brings great challenges to its accurate monitoring. At present, the asparaginase activity detection methods included in the pharmacopoeias of various countries are mainly applicable to sample types such as raw materials and drug preparations. However, there are a large number of endogenous protein and polypeptide substances with similar structural properties in biological samples, which interfere with the accurate detection of asparaginase activity, and are limited by low sensitivity and cannot be applied to the detection of asparaginase activity in vivo. The existing enzyme-linked immunosorbent assay can be used for enzyme activity detection in biological samples, but it is expensive, cumbersome and time-consuming, and it is difficult to meet the practical application needs of asparaginase activity detection in large quantities of biological samples. The traditionally recognized analytical methods for in vivo protease bioactivity are mainly enzyme-linked immunosorbent assay and radioimmunoassay, but they have shortcomings such as narrow quantitative range, low selectivity, and high price. How to establish a dedicated and sensitive analytical method for asparaginase bioactivity is of great practical significance.
[0005] Magnetic nanoparticles have the advantages of superparamagnetism, easy modification, and rapid separation, and they have shown significant advantages in the separation and analysis of biological macromolecules that are easily interfered by biological matrices. Antibodies that specifically recognize asparaginase are modified on the surface of magnetic nanoparticles to achieve exclusive separation and enrichment of asparaginase in biological samples, effectively avoiding interference from the biological sample matrix and further improving the sensitivity of detection.
[0006] As the main method for in vivo analysis of small molecule compounds, LC-MS / MS has many advantages such as ultra-high selectivity, high sensitivity, and simultaneous quantitative analysis of multiple components. However, the use of LC-MS / MS to monitor protease activity in biological samples still faces many challenges, including the difficulty of directly detecting enzyme activity using mass spectrometry as a mass detector, and the need to use enzyme analysis or enzymatic analysis to analyze the change in the amount of enzyme substrate or product to achieve enzyme activity monitoring. In addition, as a biological macromolecule, protease has low ionization efficiency and weak mass spectrometry detection signal. It is mainly based on the proteolysis method to enzymatically hydrolyze protein polypeptide biological macromolecules and select characteristic peptides for analysis and detection. However, the improvement in detection sensitivity is limited, and due to high operating requirements, it is easy to introduce large errors. Therefore, how to combine highly sensitive and exclusive LC-MS / MS analysis methods to detect asparaginase activity in biological samples has important practical significance. Summary of the invention
[0007] The purpose of the present invention is to provide a method for specifically detecting asparaginase activity in a sample by immunomagnetic separation combined with substrate peptides by LC-MS. The method of the present invention can be used to monitor the activity level of asparaginase in vivo, thereby effectively monitoring and preventing allergic reactions of asparaginase, and at the same time providing guidance for the adjustment of drug treatment plans.
[0008] In order to achieve the above object, the present invention adopts the following technical solution:
[0009] The asparaginase antibody is coupled to the surface of magnetic nanoparticles by amide reaction to prepare immunomagnetic beads, and asparaginase in biological samples is specifically captured and enriched by immunomagnetic beads, and endogenous interfering matrix in biological samples is removed by external magnetic field; secondly, an excess of asparaginase substrate asparagine solution is added to the enriched sample, and then asparaginase exclusively cleaves the substrate to generate aspartic acid and ammonia, and the aspartic acid level in the sample supernatant is quantitatively analyzed by LC-MS / MS. Under certain conditions, the reduction of substrate peptide is proportional to the asparaginase activity, that is, the amount of product aspartic acid is proportional to the asparaginase activity. Therefore, the product aspartic acid is used instead of asparaginase for LC-MS / MS analysis, and the asparaginase activity is used as the horizontal coordinate and the signal intensity of aspartic acid is used as the vertical coordinate to establish an asparaginase activity-mass spectrometry response signal standard curve. The sample to be tested is processed according to the above steps and then injected for analysis, and the obtained aspartic acid signal intensity is substituted into the standard curve, thereby realizing the detection of asparaginase activity.
[0010] The present invention is based on the preparation of immunomagnetic beads by coupling asparaginase antibodies through amide reaction mediation, and is dedicated to the separation and enrichment of asparaginase in samples. It is based on the specific cleavage of substrate peptide asparagine by asparaginase, and after adding asparagine solution for reaction, it can realize the direct and highly sensitive detection of asparaginase activity by LC-MS / MS. It not only avoids the limitation that LC-MS / MS cannot directly detect protease activity, but also effectively improves the sensitivity of detection, and realizes mass spectrometry monitoring of asparaginase activity through pretreatment of immunomagnetic beads.
[0011] Based on the above technical solution, the first aspect of the present invention provides a method for specifically detecting asparaginase activity by immunomagnetic separation combined with substrate peptides by LC-MS / MS, comprising the following steps:
[0012] A) using an amide reaction to mediate coupling of asparaginase antibodies to the surface of magnetic nanoparticles to prepare immunomagnetic beads; the immunomagnetic beads are antibody immune functionalized magnetic beads obtained by coupling magnetic beads with asparaginase antibodies;
[0013] B) adding different amounts of asparaginase standard to blank biological samples to prepare asparaginase-containing samples of different concentrations, and performing specific capture and enrichment with immunomagnetic beads to obtain immunomagnetic bead / asparaginase complexes corresponding to each sample; adding asparaginase substrate peptide to the immunomagnetic bead / asparaginase complex, and asparagine-specific cleavage of the substrate peptide to form aspartic acid and ammonia, and detecting the supernatant of the sample by LC-MS / MS, with the concentration of asparaginase as the abscissa and the intensity of aspartic acid signal detected by mass spectrometry as the ordinate, to establish a standard curve of asparaginase-mass spectrometry response signal;
[0014] C) After the sample to be tested is mixed and incubated with the immunomagnetic beads, a substrate peptide asparagine solution is added for LC-MS / MS detection, and the obtained aspartic acid signal intensity is substituted into the standard curve to calculate the activity of asparaginase in the sample to be tested.
[0015] Furthermore, the sample to be tested is a blood sample.
[0016] Furthermore, the method of immunomagnetic separation combined with substrate peptide to specifically detect in vivo asparaginase activity by LC-MS / MS specifically comprises the following steps:
[0017] (a) FeO magnetic nanoparticles were prepared by a hydrothermal method, and then an agarose molecular layer was introduced in situ on the surface of the magnetic nanoparticles, and the N-hydroxysuccinimide (NHS) activated ester groups were further modified to prepare NHS magnetic beads;
[0018] (b) pipetting the NHS-activated magnetic nanoparticle dispersion, removing the supernatant by magnetic separation, quickly adding pre-cooled hydrochloric acid solution to mix and wash, and removing the supernatant by magnetic separation;
[0019] (c) adding monoclonal antibody to asparaginase, rotating and mixing at 4°C in the dark for 12 h, and removing the supernatant by magnetic separation;
[0020] (d) Under an external magnetic field, the cells were washed four times with 100 mM Tris-HCl (containing 150 mM NaCl, pH 8.0) buffer, redispersed in 100 mM Tris-HCl (containing 150 mM NaCl, pH 8.0), and sealed for 2 h at room temperature with rotation and in the dark. The supernatant was removed by magnetic separation.
[0021] (e) The magnetic beads were washed 4 times by pipetting and mixing in 10 mM PBS (containing 137 mM NaCl, pH 7.4) containing 5 wt % BSA, and redispersed in 10 mM PBS (containing 137 mM NaCl, pH 7.4) containing 5 wt % BSA, and blocked with rotation at 4° C. in the dark for 12 h;
[0022] (f) removing the supernatant by magnetic separation, washing the mixture four times with PBS containing 0.1 wt % BSA and then re-dispersing the mixture to obtain antibody immunofunctionalized magnetic beads;
[0023] (g) taking the prepared antibody immunofunctionalized magnetic bead suspension, applying a magnetic field to separate and remove the supernatant, and diluting with 5 volumes of 2 wt% BSA in PBS;
[0024] (h) adding the test sample or standard sample containing asparaginase, and mixing and reacting for 2 hours at room temperature;
[0025] (i) applying an external magnetic field to remove the supernatant, washing three times with washing buffer, and applying an external magnetic field to remove the supernatant;
[0026] (j) Add asparagine phosphate buffer and shake at 37°C for 15 min; add 4 times the volume of acetonitrile containing internal standard, vortex mix thoroughly for 1 min, centrifuge and quantitatively remove the supernatant, dilute 600 times with 85% acetonitrile-water mixed solution, vortex mix, and transfer to a sample injection vial;
[0027] (k) Analytical detection was performed using LC-MS / MS method.
[0028] Furthermore, in the step c, 1 volume of 0.5 mg / mL asparaginase monoclonal antibody is added.
[0029] Furthermore, in the step j, a phosphate buffer (pH 8.0, 100 mM) containing 5.0 mg / mL asparagine is added.
[0030] Furthermore, in the step j, the volume ratio of acetonitrile to water in the acetonitrile-water mixed solution is 85:15.
[0031] Furthermore, the method for analyzing and detecting by the LC-MS / MS method comprises the following steps:
[0032] (a) Chromatographic conditions: Shimadzu GL Inertsil HILIC column (2.1 × 75 mm, 3 μm), mobile phase: 0.05% formic acid in water (A)-0.05% formic acid in acetonitrile (B) (15:85, v / v), isocratic elution, flow rate of 0.3 mL / min, column temperature of 35 °C, injection volume of 1 μL, analysis time of 2 min;
[0033] (b) Mass spectrometry conditions: Shimadzu 8045 triple quadrupole mass spectrometer, ESI as ion source, multiple reaction monitoring (MRM) scanning mode, detection in positive ion mode, m / z of aspartic acid parent ion and daughter ion are 134.0 and 74.0, respectively, collision energy is -30 eV, m / z of asparagine parent ion and daughter ion are 133.0 and 74.0, respectively, CE is -35 eV.
[0034] The present invention has the advantages that:
[0035] 1. The preparation of immunomagnetic beads using NHS magnetic nanoparticles has the advantages of high efficiency, rapidity and easy operation.
[0036] 2. Use immune-functionalized magnetic beads to specifically separate and enrich the asparaginase to be tested, so as to achieve the purpose of specific separation of the test object and avoid interference from the sample matrix.
[0037] 3. Asparaginase is used to specifically cleave asparagine to generate aspartic acid, and the reduction of asparagine or the increase of aspartic acid is detected by mass spectrometry to achieve the purpose of detecting asparaginase activity.
[0038] 4. Establish a highly sensitive LC-MS / MS analysis method to quantitatively analyze and detect the changes in the amounts of small molecule compounds aspartic acid and asparagine, and further improve the detection sensitivity.
[0039] In summary, the detection method of the present invention has high sensitivity, good specificity and is easy to operate. By means of magnetic separation, the asparaginase to be detected in the enriched sample is quickly and exclusively separated, combined with the characteristics of asparaginase as a protease that specifically cleaves the substrate peptide asparagine, the asparaginase is efficiently and exclusively cleaved to generate a large amount of aspartic acid, and the asparaginase activity is detected by mass spectrometry, which significantly improves the sensitivity of detecting asparaginase activity, and has important practical significance for promoting the monitoring of the activity level of asparaginase in vivo. BRIEF DESCRIPTION OF THE DRAWINGS
[0040] Figure 1 This is a TEM characterization image of the magnetic nanoparticles prepared in Example 1 of the present invention.
[0041] Figure 2 This is a TEM characterization image of the NHS magnetic nanoparticles prepared in Example 1 of the present invention.
[0042] Figure 3 This is a graph showing the results of optimizing the concentration of the substrate asparagine solution added in Example 3 of the present invention.
[0043] Figure 4 This is the ion scanning diagram of aspartic acid in Example 3 of the present invention.
[0044] Figure 5 This is a mass spectrometry detection diagram of the asparaginase-containing sample in Example 3 of the present invention. DETAILED DESCRIPTION
[0045] The specific implementation methods provided by the present invention are described in detail below in conjunction with examples.
[0046] Example 1: Preparation of immunofunctionalized magnetic beads
[0047] 0.5 g of FeCl3·6H2O was weighed and dissolved in 20 mL of ethylene glycol. After sufficient ultrasonic treatment to form a clear solution, 1.5 g of NaOAc was added and dissolved evenly. The mixed solution was transferred to a stainless steel autoclave lined with polytetrafluoroethylene and heated at 200°C for 12 hours. After cooling, the obtained black product was washed three times with anhydrous ethanol and ultrapure water respectively, to obtain monodispersed Fe3O4 magnetic nanoparticles. 1.0 g of the prepared monodispersed Fe3O4 magnetic nanoparticles were ultrasonically dispersed in 2 mL of phosphate buffer solution (10 mM, pH 7.0). After being fully dispersed by ultrasonication for more than 20 min, 1.5 mL of epichlorohydrin was added, and the mixture was mechanically stirred for 2 h at room temperature, and then mechanically stirred for 40 min at 50 ° C. Then, 2 mg / mL of chitosan solution was added to react overnight, and an external magnetic field was applied to obtain Fe3O4-chitosan magnetic nanoparticles. Then, the mixture was activated by N-hydroxysuccinimide and fully ultrasonically dispersed and stored in N, N-dimethylacetamide to obtain a 10 mg / mL N-hydroxysuccinimide-activated magnetic nanoparticle dispersion. The N-hydroxysuccinimide-activated magnetic nanoparticle dispersion was removed, the supernatant was removed by magnetic separation, and 2 volumes of 4 ° C pre-cooled hydrochloric acid solution were quickly added. After being fully vortexed for 30 s, the supernatant was removed by magnetic separation. 1 volume of asparaginase monoclonal antibody (0.5 mg / mL) was added, and the mixture was mixed and rotated at 4°C in the dark for 12 h. The supernatant was removed by magnetic separation. Under the condition of an external magnetic field, the beads were repeatedly washed 4 times with 1 volume of 100 mM Tris-HCl (containing 150 mM NaCl, pH 8.0) buffer, redispersed in an equal volume of 100 mM Tris-HCl (containing 150 mM NaCl, pH 8.0), blocked at room temperature in the dark for 2 h, and the supernatant was removed by magnetic separation. The magnetic beads were washed 4 times with an equal volume of 10 mM PBS (containing 137 mM NaCl, pH 7.4) containing 5% BSA by pipetting and mixing, and redispersed in an equal volume of 10 mM PBS (containing 137 mM NaCl, pH 7.4) containing 5% BSA, and further blocked for 12 h at 4°C in the dark. After blocking, the supernatant was removed by magnetic separation, and the beads were washed four times with PBS containing 0.1% BSA and then dispersed to obtain antibody immunofunctionalized magnetic beads.
[0048] An appropriate amount of the synthesized NHS magnetic nanoparticles was taken for transmission electron microscopy (TEM) characterization to evaluate the morphology and distribution of the NHS magnetic nanoparticles used in the method.
[0049] Figure 1 This is a TEM characterization image of the magnetic nanoparticles prepared in this example. Figure 2 This is a TEM characterization image of the NHS magnetic nanoparticles prepared in this example.
[0050] like Figure 1 and Figure 2 As shown, the prepared magnetic nanoparticles have uniform particle size distribution, and the surface of NHS magnetic nanoparticles is successfully coated with chitosan.
[0051] An appropriate amount of the synthesized magnetic nanoparticles was taken for Dynamic Light Scattering (DLS) characterization to evaluate the particle size distribution of the NHS magnetic beads prepared by this method.
[0052] DLS characterization results showed that the particle size distribution of the prepared NHS magnetic beads was uniform, about 396±31nm.
[0053] Example 2: Immunofunctionalized magnetic beads specifically enrich asparaginase in samples
[0054] The prepared antibody immunofunctionalized magnetic bead suspension was removed, and the supernatant was removed by applying a magnetic field, and the suspension was diluted with 5 times the volume of PBS containing 0.1% BSA, and the supernatant was removed by applying a magnetic field, and the test sample or standard sample containing asparaginase was added, and the mixture was rotated and mixed for 2 hours at room temperature, and the supernatant was removed by applying a magnetic field, and the suspension was washed 3 times by shaking with a washing buffer of 10mM PBS (containing 137mM NaCl, 0.05% Tween-20 (w / v), pH7.4), and the supernatant was removed by applying a magnetic field.
[0055] Example 3: LC-MS / MS specific sensitive analysis of asparaginase activity
[0056] Add the optimal concentration of asparagine phosphate solution (100 mM, pH 8.0) to the enriched sample, react at 37°C for 15 min, add 4 times the volume of acetonitrile containing the internal standard, vortex mix thoroughly for 1 min, centrifuge and quantitatively remove the supernatant, dilute 600 times with acetonitrile-water mixed solution (85:15, v / v), vortex mix, transfer to an injection vial, and analyze and detect using the established LC-MS / MS method.
[0057] The LC-MS / MS method was as follows: Shimadzu GL Inertsil HILIC column (2.1×75 mm, 3 μm), mobile phase: 0.05% formic acid water (A)-0.05% formic acid acetonitrile (B) (15:85, v / v), isocratic elution, flow rate of 0.3 mL / min, column temperature of 35°C, injection volume of 1 μL, and analysis time of 2 min. Shimadzu 8045 triple quadrupole mass spectrometer, ion source of ESI, scanning mode of multiple reaction monitoring (MRM), detection in positive ion mode, aspartic acid parent ion and daughter ion m / z of 134.0, 74.0, collision energy of -30 eV, asparagine parent ion and daughter ion m / z of 133.0, 74.0, CE of -35 eV.
[0058] Mass spectrometric ion scans were performed for the asparagine substrate peptides and aspartic acid used.
[0059] Figure 3 Graph showing the results of optimizing the concentration of the substrate asparagine solution added in this example. Figure 3 As shown, when the concentration of the added substrate asparagine solution was 5.00 mg / mL, the linear correlation between the reduction amount of asparagine and the asparaginase concentration was the best.
[0060] Figure 4 : is the ion scan of aspartic acid in this example. Figure 4 As shown, the m / z of the aspartic acid parent ion and the daughter ion are 134.0 and 74.0, respectively, and the m / z of the asparagine parent ion and the daughter ion are 133.0 and 74.0, respectively.
[0061] The obtained samples were subjected to mass spectrometry analysis.
[0062] Figure 5 : is the mass spectrometry detection diagram of the sample containing asparaginase in this embodiment. Figure 5 As shown, the mass spectrometry detection peak shape of the serum sample containing 0.05 IU / mL asparaginase is good, and there are no other interfering impurity peaks, indicating that the analytical method of the present invention is unique and sensitive and can meet the needs of in vivo asparaginase activity detection.
[0063] The preferred embodiments of the present invention have been specifically described above, but the present invention is not limited to the embodiments. Those skilled in the art may make various equivalent modifications or substitutions without violating the spirit of the present invention. These equivalent modifications or substitutions are all included in the scope defined by the claims of this application.
Claims
1. A method for specifically detecting asparaginase activity by immunomagnetic separation combined with substrate peptides using LC-MS / MS, characterized in that: The following steps are involved: A) using an amide reaction to mediate coupling of asparaginase antibodies to the surface of magnetic nanoparticles to prepare immunomagnetic beads; the immunomagnetic beads are antibody immune functionalized magnetic beads obtained by coupling magnetic beads with asparaginase antibodies; B) adding different amounts of asparaginase standard to blank biological samples to prepare asparaginase-containing samples of different concentrations, and performing specific capture and enrichment with immunomagnetic beads to obtain immunomagnetic bead / asparaginase complexes corresponding to each sample; adding asparaginase substrate peptide to the immunomagnetic bead / asparaginase complex, and asparagine-specific cleavage of the substrate peptide to form aspartic acid and ammonia, and detecting the supernatant of the sample by LC-MS / MS, with the concentration of asparaginase as the abscissa and the intensity of aspartic acid signal detected by mass spectrometry as the ordinate, to establish a standard curve of asparaginase-mass spectrometry response signal; C) After the sample to be tested is mixed and incubated with the immunomagnetic beads, a substrate peptide asparagine solution is added for LC-MS / MS detection, and the obtained aspartic acid signal intensity is substituted into the standard curve to calculate the activity of asparaginase in the sample to be tested.
2. The method for specific detection of in vivo asparaginase activity by immunomagnetic separation combined with substrate peptide by LC-MS / MS according to claim 1, characterized in that: The following steps are involved: (a) FeO magnetic nanoparticles were prepared by a hydrothermal method, and then an agarose molecular layer was introduced in situ on the surface of the magnetic nanoparticles, and the NHS activated ester groups were further modified to prepare NHS magnetic beads; (b) pipetting the NHS-activated magnetic nanoparticle dispersion, removing the supernatant by magnetic separation, quickly adding pre-cooled hydrochloric acid solution to mix and wash, and removing the supernatant by magnetic separation; (c) adding monoclonal antibody to asparaginase, rotating and mixing at 4°C in the dark for 12 h, and removing the supernatant by magnetic separation; (d) Under an external magnetic field, the cells were washed four times with 100 mM Tris-HCl buffer, redispersed in 100 mM Tris-HCl, and sealed for 2 h at room temperature with rotation and in the dark. The supernatant was removed by magnetic separation. (e) Wash the beads four times with 10 mM PBS containing 5% BSA by pipetting and mixing, redisperse in 10 mM PBS containing 5% BSA, and block at 4°C with rotation and in the dark for 12 h; (f) removing the supernatant by magnetic separation, washing the mixture four times with PBS containing 0.1% BSA and then re-dispersing the mixture to obtain antibody immunofunctionalized magnetic beads; (g) taking the prepared antibody immunofunctionalized magnetic bead suspension, applying a magnetic field to separate and remove the supernatant, and diluting with 5 volumes of 2% BSA in PBS; (h) adding the test sample or standard sample containing asparaginase, and mixing and reacting for 2 hours at room temperature; (i) applying an external magnetic field to remove the supernatant, washing three times with washing buffer, and applying an external magnetic field to remove the supernatant; (j) Add asparagine phosphate buffer at pH 8.0, shake well and react at 37°C for 15 min; add 4 times the volume of acetonitrile containing internal standard, vortex mix thoroughly for 1 min, centrifuge and quantitatively remove the supernatant, dilute 600 times with 85% acetonitrile-water mixed solution, vortex mix, and transfer to a sample injection vial; (k) Analytical detection was performed using LC-MS / MS method.
3. The method for specific detection of in vivo asparaginase activity by immunomagnetic separation combined with substrate peptide by LC-MS / MS according to claim 2, characterized in that: In the step c, 1 volume of 0.5 mg / mL asparaginase monoclonal antibody is added.
4. The method for specific detection of in vivo asparaginase activity by immunomagnetic separation combined with substrate peptide by LC-MS / MS according to claim 2, characterized in that: In the step d, the Tris-HCl buffer contains 150 mM NaCl and has a pH of 8.
0.
5. The method for specific detection of in vivo asparaginase activity by immunomagnetic separation combined with substrate peptide by LC-MS / MS according to claim 2, characterized in that: In the step e, PBS contains 137 mM NaCl and has a pH of 7.
4.
6. The method for specific detection of in vivo asparaginase activity by immunomagnetic separation combined with substrate peptide by LC-MS / MS according to claim 2, characterized in that: In the step j, the concentration of the asparagine solution is 5.0 mg / mL.
7. The method for specific detection of in vivo asparaginase activity by immunomagnetic separation combined with substrate peptide by LC-MS / MS according to claim 2, characterized in that: In the step j, the volume ratio of acetonitrile to water in the acetonitrile-water mixed solution is 85:
15.
8. The method for specific detection of in vivo asparaginase activity by immunomagnetic separation combined with substrate peptide by LC-MS / MS according to claim 2, characterized in that: The method for analyzing and detecting by the LC-MS / MS method comprises the following steps: (a) Chromatographic conditions: Shimadzu GL Inertsil HILIC column (2.1 × 75 mm, 3 μm), mobile phase: 0.05% formic acid in water (A)-0.05% formic acid in acetonitrile (B) (15:85, v / v), isocratic elution, flow rate of 0.3 mL / min, column temperature of 35 °C, injection volume of 1 μL, analysis time of 2 min; (b) Mass spectrometry conditions: Shimadzu 8045 triple quadrupole mass spectrometer, ESI as ion source, multiple reaction monitoring as scanning mode, detection in positive ion mode, m / z of aspartic acid parent ion and daughter ion are 134.0 and 74.0, respectively, collision energy is -30 eV, m / z of asparagine parent ion and daughter ion are 133.0 and 74.0, respectively, CE is -35 eV.
Citation Information
Patent Citations
Tests used to predict the neutralizing effect on asparaginase activity
CN102272323A
Method for determining concentrations of endogenous amino acid asparagines and glutamine through LC-MS
CN103822981A
LC-MS (Liquid Chromatograph-Mass Spectrometer) quantitative method for detecting protein drug in body on basis of label small molecule exclusive separation-amplification and application of protein drug
CN108120781A
Complement activation C1s enzyme fluorescence detection kit, detection method and application
CN114874329A
Quantification of enzyme activity by mass spectrometry using immobilized substrates
US20110281289A1
